Skip to main content
Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain flag Spain · Delayed Price · Currency is EUR
80.35
-0.90 (-1.11%)
Mar 5, 2026, 9:13 AM CET

BME:ROVI Revenue

In the year 2025, Laboratorios Farmaceuticos Rovi had annual revenue of 743.48M EUR, down -2.65%. Laboratorios Farmaceuticos Rovi had revenue of 218.42M in the quarter ending December 31, 2025, with 9.68% growth.

Revenue
743.48M
Revenue Growth
-2.65%
P/S Ratio
5.59
Revenue / Employee
372.11K
Employees
2,188
Market Cap
4.16B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025743.48M-20.27M-2.65%
Dec 31, 2024763.75M-65.76M-7.93%
Dec 31, 2023829.51M11.81M1.44%
Dec 31, 2022817.70M169.02M26.06%
Dec 31, 2021648.68M228.72M54.46%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 7.52B
Almirall 1.11B
Faes Farma 571.12M
Pharma Mar 179.28M
Clínica Baviera 296.76M
Prim, S.A. 240.68M
Oryzon Genomics 7.36M
Atrys Health 226.24M
Revenue Rankings

Laboratorios Farmaceuticos Rovi News

More News